Combination of autologous transplantation of G-CSF-mobilized peripheral blood mononuclear cells and panax notoginseng saponins in the treatment of unreconstructable critical limb ischemia

Annals of Vascular Surgery

Volumn 28, Issue 6, 2014, Pages 1501-1512

  Wang, Xiuchun ^a   Jiang, Liping ^b   Wang, Xuemei ^a   Yin, Fengling ^a   Li, Guixin ^a   Feng, Xueqiang ^a   Wang, Kai ^a   Sun, Shunji ^a  

^a AFFILIATED HOSPITAL OF WEIFANG MEDICAL UNIVERSITY   (China)

^b WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HEPARIN; PANAX NOTOGINSENG SAPONIN; RECOMBINANT COLONY STIMULATING FACTOR; SAPONIN; UNCLASSIFIED DRUG; XUE SHUAN TONG; GRANULOCYTE COLONY STIMULATING FACTOR; HERBACEOUS AGENT;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; AUTOTRANSPLANTATION; CHILL; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE REACTION; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PANAX NOTOGINSENG; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; THERAPY EFFECT; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSCUTANEOUS OXYGEN MONITORING; URTICARIA; VERY ELDERLY; ADVERSE EFFECTS; CHEMISTRY; CHINA; CRITICAL ILLNESS; DIGITAL SUBTRACTION ANGIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEMODYNAMICS; ISCHEMIA; ISOLATION AND PURIFICATION; LEG; MEDICINAL PLANT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYTOTHERAPY; TIME; TREATMENT OUTCOME; VASCULARIZATION; WOUND HEALING;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANKLE BRACHIAL INDEX; CHINA; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; DRUGS, CHINESE HERBAL; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMODYNAMICS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; PANAX NOTOGINSENG; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYTOTHERAPY; PLANTS, MEDICINAL; SAPONINS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84905099374     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2014.03.002     Document Type: Article

References (33)

1. M.K. Mamidi, R. Pal, and S. Dey et al. Cell therapy in critical limb ischemia: current developments and future progress Cytotherapy 14 2012 902 916
2. M.G. Davies Criticial limb ischemia: epidemiology Methodist Debakey Cardiovasc J 8 2012 10 14
3. Z. Raval, and D.W. Losordo Cell therapy of peripheral arterial disease: from experimental findings to clinical trials Circ Res 112 2013 1288 1302
4. L. Norgren, W.R. Hiatt, and J.A. Dormandy et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl 1 2007 S1 S75
5. A.T. Hirsch Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting Circulation 114 2006 2581 2583
6. G.O. Ouma, B. Zafrir, and E.R. Mohler 3rd et al. Therapeutic angiogenesis in critical limb ischemia Angiology 64 2013 466 480
7. M.D. Weinberg, J.F. Lau, and K. Rosenfield et al. Peripheral artery disease. Part 2: medical and endovascular treatment Nat Rev Cardiol 8 2011 429 441
8. M. Romiti, M. Albers, and F.C. Brochado-Neto et al. Meta-Analysis of infrapopliteal angioplasty for chronic critical limb ischemia J Vasc Surg 47 2008 975 981
9. L. Norgren, W.R. Hiatt, and J.A. Dormandy et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
10. W.A. Marston, S.W. Davies, and B. Armstrong et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization J Vasc Surg 44 2006 108 114
11. T. Asahara, T. Murohara, and A. Sullivan et al. Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
12. P.P. Huang, S.Z. Li, and M.Z. Han et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities Thromb Haemost 91 2004 606 609
13. P. Huang, S. Li, and M. Han et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes Diabetes Care 28 2005 2155 2160
14. P.P. Huang, X.F. Yang, and S.Z. Li et al. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans Thromb Haemost 98 2007 1335 1342
15. X. Chen, M. Zhou, and Q. Li et al. Sanchi for acute ischaemic stroke Cochrane Database Syst Rev 8 2008 CD006305
16. T.B. Ng Pharmacological activity of sanchi ginseng (Panax notoginseng) J Pharm Pharmacol 58 2006 1007 1019
17. Y. Liu, F. Hao, and H. Zhang et al. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice Cell Physiol Biochem 32 2013 814 826
18. Y. Kawachi, A. Watanabe, and T. Uchida et al. Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor Br J Haematol 94 1996 413 416
19. Y. Fukumoto, T. Miyamoto, and T. Okamura et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia Br J Haematol 97 1997 666 668
20. E. Tateishi-Yuyama, H. Matsubara, and T. Murohara et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 360 2002 427 435
21. M. Hristov, W. Erl, and P.C. Weber Endothelial progenitor cells: mobilization, differentiation, and homing Arterioscler Thromb Vasc Biol 23 2003 1185 1189
22. J. Geng, W. Peng, and Y. Huang et al. Ginsenoside-Rg1 from Panax notoginseng prevents hepatic fibrosis induced by thioacetamide in rats Eur J Pharmacol 634 2010 162 169
23. X.D. Peng, L.L. Dai, and C.Q. Huang et al. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis Biochem Biophys Res Commun 388 2009 31 34
24. X.S. Xie, M. Yang, and H.C. Liu et al. Influence of ginsenoside Rg1, a panaxatriol saponin from Panax notoginseng, on renal fibrosis in rats with unilateral ureteral obstruction J Zhejiang Univ Sci B 9 2008 885 894
25. J. Wang, J. Xu, and J.B. Zhong [Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome] Zhongguo Zhong Xi Yi Jie He Za Zhi 24 2004 312 316
26. K.Z. Liu, J.B. Li, and H.L. Lu et al. [Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy] Zhongguo Zhong Yao Za Zhi 29 2004 264 266
27. D. Zhu, L. Wu, and C.R. Li et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis J Cell Biochem 108 2009 117 124
28. Z.L. Zhang, Y. Fan, and M.L. Liu Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia/reoxygenation Mol Cell Biochem 365 2012 243 250
29. R. Ross Atherosclerosis is an inflammatory disease Am Heart J 138 1999 S419 S420
30. S.S. Signorelli, M. Anzaldi, and V. Fiore Inflammation in peripheral arterial disease (PAD) Curr Pharm Des 18 2012 4350 4357
31. A. Flex, E. Gaetani, and F. Angelini et al. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia J Intern Med 262 2007 124 130
32. K. Cassar, P. Bachoo, and I. Ford et al. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease Eur J Vasc Endovasc Surg 29 2005 171 176
33. Y. Liu, H.G. Zhang, and Y. Jia et al. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits Biol Pharm Bull 33 2010 1324 1330